Skip to main
CALT
CALT logo

CALT Earnings Dates & Reports

CALT Most Recent Earnings

Report DateAug 13, 2024
Period EndingQ2 2024
Est. EPS-$0.10
Actual EPS-$0.16
EarningsMiss

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

CALT Earnings per Share (EPS) History

Signup for full access
Browse free

CALT Latest Earnings

The value each CALT share was expected to gain vs. the value each share gained.

CALT reported its most recent earnings on Aug 13, 2024 for Q2 2024, posting earnings per share (EPS) of -$0.16. This exceeded analysts' expectations of -$0.10 by 60.00%, marking a Miss.

For comparison, Calliditas Therapeutics AB reported EPS of -$0.33 in the same quarter last year.

The company is expected to announce its next earnings report on 08/13/2024, with analysts projecting an EPS of $0.

CALT Earnings History

Earnings
Est. EPSActual EPSSurprise
Q2 2024Aug 13, 2024
-$0.10-$0.16+60.00%
DeckReportListen
Q1 2024May 23, 2024
-$0.14-$0.88+528.57%
DeckReportListen
Q4 2023Feb 21, 2024
-$0.07-$0.06-8.57%
DeckReportListen
Q3 2023Nov 7, 2023
-$0.31-$0.58+87.10%
DeckReportListen
Q2 2023Aug 17, 2023
-$0.18-$0.33+80.56%
DeckReportListen
View all

CALT Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Calliditas Therapeutics AB’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
May 23, 2024
Feb 21, 2024
Nov 7, 2023
Aug 17, 2023

CALT Earnings FAQs

CALT last reported earnings on Aug 13, 2024 for Q2 2024, posting an EPS of -$0.16, which Miss the estimate of -$0.10 by 60.00%.

For Q2 2024, CALT reported an EPS of -$0.16, missing analysts' estimate of -$0.10 by 60.00%.

For Q2 2024, CALT Miss expectations with an actual EPS of -$0.16 vs. an estimated EPS of -$0.10.

Following the last earnings report on Aug 13, 2024, CALT's stock price moved — from — to —.

The next CALT earnings call is scheduled for Aug. 13, 2024, where executives will discuss financial results and outlook.

Calliditas Therapeutics AB (CALT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.